Irinotecan, vincristine, cisplatin, cyclophosphamide, and etoposide for refractory or relapsed medulloblastoma/PNET in pediatric patients

Response to bevacizumab, irinotecan, and temozolomide in children with relapsed medulloblastoma: a multi-institutional experience

(2013) Dolly Aguilera et al.   CHILDS NERVOUS SYSTEM

High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma

(2011) I. J. Dunkel et al.   NEURO-ONCOLOGY

Efficacy of High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Relapsed Medulloblastoma: A Report on The Korean Society for Pediatric Neuro-Oncology (KSPNO)-S-053 Study

(2010) Jun Eun Park et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue

(2009) Howard Grodman et al.   PEDIATRIC BLOOD & CANCER

Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumors

(2008) Adam S. Levy et al.   CANCER

High-dose chemotherapy with autologous stem cell rescue for children with recurrent malignant brain tumors

(2008) Chie-Schin Shih et al.   CANCER